Analyst Price Target is $68.29
▲ +2.18% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Solventum in the last 3 months. The average price target is $68.29, with a high forecast of $82.00 and a low forecast of $54.00. The average price target represents a 2.18% upside from the last price of $66.83.
Current Consensus is
Hold
The current consensus among 11 contributing investment analysts is to hold stock in Solventum. This rating has held steady since September 2024, when it changed from a Reduce consensus rating.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Read More
